Homepage
Medication Guide
How Effective is Vibegron in Treatment?
Vibegron is a selective β-3 adrenergic receptor agonist that was first approved for marketing in the United States in 2020. As an innovative drug for the treatment of overactive bladder (OAB), it prov...
505
Monday, September 15th, 2025, 14:56
Precautions for Vibegron Administration
Vibegron is a selective β3-adrenergic receptor agonist. It was first approved in the United States in 2020 for the treatment of overactive bladder (OAB) in adults. As a novel drug for OAB treatment, V...
503
Monday, September 15th, 2025, 14:51
How to Use Vibegron (Vibegron)
Vibegron is a selective β3-adrenergic receptor agonist. Approved in 2020, it is used for the treatment of overactive bladder (OAB) in adults, with symptoms including urge urinary incontinence, urgency...
505
Monday, September 15th, 2025, 14:33
Indications of Vibegron (Vibegron)
Vibegron is a selective β3-adrenergic receptor agonist developed by Urovant Sciences. It was first approved for marketing in the United States in 2020. As an innovative drug, it provides a new treatme...
505
Monday, September 15th, 2025, 14:17
Precautions for Administration of Datopotamab (Datroway)
Datopotamab (Datroway) is a Trop-2-targeted antibody-drug conjugate (ADC). It was first approved in the United States in 2025 for the treatment of adult patients with unresectable or metastatic hormon...
509
Monday, September 15th, 2025, 13:47
How to Use Datopotamab (Datroway)
Datopotamab (Datroway) is a Trop-2-targeted antibody-drug conjugate (ADC). It was approved in the United States in 2025 for the treatment of HR-positive, HER2-negative advanced breast cancer.How to Us...
505
Monday, September 15th, 2025, 13:40
Indications of Datopotamab (Datroway)
Datopotamab (Datroway) is a novel Trop-2-directed antibody-drug conjugate (ADC) linked to a topoisomerase inhibitor. Developed by Daiichi Sankyo Co., Ltd., it was first approved for marketing in the U...
508
Monday, September 15th, 2025, 13:27
How to Use Avelumab (Bavencio)
Avelumab (Bavencio) is a programmed death ligand-1 (PD-L1) blocking antibody, indicated for the treatment of adult and pediatric patients aged 12 years and older with metastatic Merkel cell carcinoma ...
509
Friday, September 12th, 2025, 15:10
Indications of Avelumab (Bavencio)
Avelumab (Bavencio) is a programmed death ligand-1 (PD-L1) blocking antibody, first approved for marketing by the U.S. FDA in 2017. As an immune checkpoint inhibitor, it activates the immune system to...
504
Friday, September 12th, 2025, 15:05
What Are the Side Effects of Safinamide (Xadago)?
Safinamide (Xadago) is a type B monoamine oxidase (MAO-B) inhibitor. Used as an adjunctive therapeutic agent to levodopa/carbidopa, it is indicated for the treatment of "off" episodes in pat...
506
Friday, September 12th, 2025, 15:01
118 / 208
2071 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved